Rehab Kamel

851 citations
30 papers · 703 indexed · h-index 15
Topics
Synthesis and biological activity (7 papers)Synthesis and Characterization of Heterocyclic Compounds (5 papers)Receptor Mechanisms and Signaling (5 papers)
Partner nations
EgyptUnited StatesFrance

In The Last Decade

Rehab Kamel

29 papers receiving 690 citations

Peers

Rehab Kamel
Comparison fields: 5 of 85
  • Molecular Biology 197
  • Organic Chemistry 174
  • Immunology 105
  • Pharmacology 69
  • Physiology 65
Replace Aamer Qazi with:
Aamer Qazi United States
Ilaria Paterni Italy
Guorong Jiang China
Bedia Çakmakoğlu Türkiye
Hye In Kim South Korea
Gülperi Öktem Türkiye
Junxian Yu China
Qunyi Li China
Xiangzhong Zhao China
Yuanqiao He China
Rehab Kamel relative to Aamer Qazi United States Aamer Qazi's profile →
Citations per field
00.5×1.5×2.5×
Aamer Qazi · 1×
Citations per year

Countries citing papers authored by Rehab Kamel

Since Specialization
Citations

This map shows the geographic impact of Rehab Kamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rehab Kamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rehab Kamel more than expected).

Fields of papers citing papers by Rehab Kamel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rehab Kamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rehab Kamel. The network helps show where Rehab Kamel may publish in the future.

Co-authorship network of co-authors of Rehab Kamel

This figure shows the co-authorship network connecting the top 25 collaborators of Rehab Kamel. A scholar is included among the top collaborators of Rehab Kamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rehab Kamel. Rehab Kamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 3
4 6
5 1
6 8
7 33
8 3
9 17
10 25
11 49
12 24
13 7
14 30
15 91
16 11
17 11
18 17
19 26
20 121

About Rehab Kamel

Rehab Kamel is a scholar working on Toxicology, Pharmacology and Pathology and Forensic Medicine, having authored 30 papers that have together received 703 indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Receptor Mechanisms and Signaling (5 papers). The work is most often cited by research in Pharmacology (69 citations), Complementary and alternative medicine (54 citations) and Toxicology (22 citations). Rehab Kamel has collaborated with scholars based in Egypt, United States and France. Frequent co-authors include Mosaad S. Mohamed, Engy M. El Morsy, Samar S. Fatahala, Yves Landry, Azza S. Awad, Maha A.E. Ahmed, Abeer Elkhoely, Pierre Eftekhari, Amany A.E. Ahmed and Riham S. Said. Their work appears in journals such as Scientific Reports, Biochemical Pharmacology and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026